NT-proBNP Sebagai Parameter Awal untuk membedakan sesak Nafas akibat Gagal Jantung dan bukan Gagal Jantung di Instalasi Gawat Darurat RSUP. H. Adam Malik
63
DAFTAR PUSTAKA
1. Panggabean MM. Gagal jantung. In: Sudoyo AW, Setyohadi B, Alwi
I, Simadibrata M, Setiati S, editor. Buku ajar ilmu penyakit dalam,4th
ed, Jakarta: Pusat Penerbit Departemen Ilmu Penyakit Dalam
Fakultas Kedokteran Universitas Indonesia; 2006:p.1513-16.
2. Braunwald E. Heart failure and cor pulmonale, in : Kasper DL, Fauci
AS, Longo DL,
Braunwald E, Hauser SL, Jameson JL, ed.
Harrison’s principles of internal medicine, ed 16. McGraw-Hill, 2005.
p1367-77.
3. Yancy et al, ACCF / American Heart
Association Heart Failure
Guideline: excecutive summary, 2013
4. RISKESDA 2007.
5. Merdawati, Haris Hasan. E-Journal FK USU Vol 1 no 1 , 2013
6. GB Antoni , Santalo M, Zapico-Mun BE, et al. N-terminal probrain
natriuretic peptide
(NT-proBNP) in the emergency diagnosis and
in-hospital monitoring of patients with dyspnea and ventricular
dysfunction. The European Journal of Heart Failure 6 (2004) 301–
308. Elsevier
7. Hersunarti N, Rohman MS. Pemeriksaan BNP atau NT- proBNP
pada Pasien Gagal Jantung. Kardiologi Indonesia J Kardiol Ind
2007; 28:229-232 ISSN 0126/3773. P: 229-32
8. Ozturk TC, Unluer E, Denizbasi A. Can NT-proBNP be used as a
criterion for heart failure hospitalization in emergency room? J. Res
Med Sci. 2011 December; 16(12): 1564–1571.
9. Ceyhan C, Unal S, Yenisey C, Tekten T, Ceyhan FB (2008). The
role of N terminal pro-brain natriuretic peptide in the evaluation of
left
ventricular
echocardiographic
diastolic
indexes
in
dysfunction-Correlation
hypertensive
patients. Int.
with
J.
Cardiovasc. Imaging., 24: 253-259
10. Angurana DK, Lone NA, Khan KA, et al. Rapid measurement of Btype natriuretic peptide in the diagnosis of congestive heart failure
in patients presenting to the emergency department with acute
63
64
shortness of breath. International Journal of Medicine and Medical
Sciences Vol. 3(3), pp. 77-82, March 2011.
11. Salim AK, Siswanto BB, Basha A. Normal value of NT-ProBNP in
Normal Indonesia Population. Buku Abstrak Pertemuan Ilmiah
Tahunan IV PDS PATKLIN ; 25 – 27 November 2005; Malang,
Indonesia
12. Anwaruddin S, LIoyd Jones DM, Baggish A, Chen A, Krauser D,
Tung R et al. Renal Function, Congestive heart failure, and aminoterminal Pro-brain natriuretic
measurement; result
from the
ProBNP Investigation of Dyspnea in the Emergency Department
( PRIDE ) Study. J Am Coll Cardiol 2006;47;917
13. Swanton RH, Banerjee S. Cardiac failure. In: Swanton’s Cardiology.
6th edition. Blackwell. 2008. P:255
14. Disalvo T. The Clinical Syndrome of Heart Failure. In: Heart Failure
Acomprehensive Guide to Diagnosis and Treatment. Ed: G William
Dec. Marcell Dekker. USA. P: 18,189.
15. Fuster
V, Rourke RA, Walsh RA, Poole-Wilson P, King III SB,
Robert R, et al. Hurst’s The Heart, ed 12. The McGraw-Hill
Companies, 2008. Chapter 24, 25, 26.
16. Dumitru I. Heart Failure. Medscape, 2013.
17. Scoote M, Purcell IA, Poole-Wilson PA. Pathophysiology of Heart
Failure. In; Essential Cardiology Principle and Practice. 2nd Edition.
Ed: CLIVE ROSENDORFF. Humana Press. USA. P: 354-367
18. Herman et al. Basics of natriuretic peptides: practical aspects of
assays, potential analytical confounders, and clinical interpretation.
In : Markers in Cardiology. ed: Allan B Wu. Humana Press. USA
2003. P : 99-103
19. Maisel AM. Rapid Measurement OF B-Type Natriuretic Peptide in
the Emergency Diagnosis of Hearth Failure. The New England
Journal of Medicine. July 2008.
20. Omland T, Waehre T. Natriuretic peptides and inflammatory
markers for risk stratification in patients with ischemic heart
64
65
disease. In:Biomarkers in Heart Disease. 1st edition.Ed: James A de
Lemos. American Heart Association. 2008. P:55-59
21. Maisel AM. Natriuretic peptide in clinical practice. In: marker in
Cardiology. Ed: Jesse E Adam. Blackwell Publishing.USA.P:134142.
22. Roundtable discussion. Testing for B-type natriuretic peptide in the
diagnosis and assessment of heart failure: What are the nuances?
Cleveland Clinic Juornal of Medicine. 2004
23. Doust J, Lehman R, Glasziou P. The Role of BNP Testing in Heart
Failure. Am Fam Physician 2006;74:1893-8
24. Jackson G et al. ABC of heart failure Pathophysiology. British
Medical Journal. BMJ Volume 320 15 January 2000
25. Dahlen
JR.
B-Type
Natriuretic
Peptide
Biochemistry
and
Measurement. In: Markers in Cardiology. ed: Allan B Wu. Humana
Press. USA 2003. P : 369-71
26. McCullough PA, Duc P, Omland T, et al. B-type natriuretic peptide
and renal function in the diagnosis of heart failure: an analysis from
the Breathing Not Properly Multinational Study. Am J Kidney Dis
2003; 41:571–579
27. Weintraub NL et al. Acute Heart Failure Syndromes: Emergency
Department Presentation, Treatment, and Disposition: Current
Approaches and Future Aims : A Scientific Statement From the
American Heart Association. Circulation Journal the American Heart
Association. AHA. October 2010
28. Rademaker MT, Richard AM. Cardiac Natriuretic Peptide for
cardiac health. Clin Sci ( Lond ).2005;108 (1):23-36
29. Pfister R et al. Use of NT-proBNP in routine testing and
comparison to BNP. The European Journal of Heart Failure.
Elsevier.2004
30. Boyars MC et al. Acute dyspea : a sign of underlying disease :
review of clinical sign.Hospital physician july 2004.pp 23-27.
31. Roche. Cobas 6000. In : Roche diagnostik.
65
66
32. Roche. Cobas
33. Mulrow C, Lucey C, Farnett L. Diskriminating cause of dyspnea
through the Clinical examination. J Gen Intern Med 1993;8:383-92.
34. Schmitt B, Kushrer M, Wiener S. The diagnostic usefulness of
history of the patient with dyspnea. J Gen Intern Med 1986;386-93
35. Morrison KL, BS, et all, Journal of American College of Cardiology
2002, Elsevier Saence Inc. vol.39,no 2,2002.
36. Murray H, Cload B, Collier CP,et all, Potential impact of N-terminal
pro-BNP testing on the emergency department evaluation of acute
dyspnea. Can J Emerg Med 2006;8(4):251-8.
37. Januzzi JL. Kimmenade RV, et all. NT-proBNP (ICON). Testing for
diagnostic and short term prognostis in acute destabilized heart
failure; an International pooled analysis of 1256 patient. The
International Collaborative of NT-proBNP (ICON) study. Eur J Heart
Failure.2006;27:330-7.
66
DAFTAR PUSTAKA
1. Panggabean MM. Gagal jantung. In: Sudoyo AW, Setyohadi B, Alwi
I, Simadibrata M, Setiati S, editor. Buku ajar ilmu penyakit dalam,4th
ed, Jakarta: Pusat Penerbit Departemen Ilmu Penyakit Dalam
Fakultas Kedokteran Universitas Indonesia; 2006:p.1513-16.
2. Braunwald E. Heart failure and cor pulmonale, in : Kasper DL, Fauci
AS, Longo DL,
Braunwald E, Hauser SL, Jameson JL, ed.
Harrison’s principles of internal medicine, ed 16. McGraw-Hill, 2005.
p1367-77.
3. Yancy et al, ACCF / American Heart
Association Heart Failure
Guideline: excecutive summary, 2013
4. RISKESDA 2007.
5. Merdawati, Haris Hasan. E-Journal FK USU Vol 1 no 1 , 2013
6. GB Antoni , Santalo M, Zapico-Mun BE, et al. N-terminal probrain
natriuretic peptide
(NT-proBNP) in the emergency diagnosis and
in-hospital monitoring of patients with dyspnea and ventricular
dysfunction. The European Journal of Heart Failure 6 (2004) 301–
308. Elsevier
7. Hersunarti N, Rohman MS. Pemeriksaan BNP atau NT- proBNP
pada Pasien Gagal Jantung. Kardiologi Indonesia J Kardiol Ind
2007; 28:229-232 ISSN 0126/3773. P: 229-32
8. Ozturk TC, Unluer E, Denizbasi A. Can NT-proBNP be used as a
criterion for heart failure hospitalization in emergency room? J. Res
Med Sci. 2011 December; 16(12): 1564–1571.
9. Ceyhan C, Unal S, Yenisey C, Tekten T, Ceyhan FB (2008). The
role of N terminal pro-brain natriuretic peptide in the evaluation of
left
ventricular
echocardiographic
diastolic
indexes
in
dysfunction-Correlation
hypertensive
patients. Int.
with
J.
Cardiovasc. Imaging., 24: 253-259
10. Angurana DK, Lone NA, Khan KA, et al. Rapid measurement of Btype natriuretic peptide in the diagnosis of congestive heart failure
in patients presenting to the emergency department with acute
63
64
shortness of breath. International Journal of Medicine and Medical
Sciences Vol. 3(3), pp. 77-82, March 2011.
11. Salim AK, Siswanto BB, Basha A. Normal value of NT-ProBNP in
Normal Indonesia Population. Buku Abstrak Pertemuan Ilmiah
Tahunan IV PDS PATKLIN ; 25 – 27 November 2005; Malang,
Indonesia
12. Anwaruddin S, LIoyd Jones DM, Baggish A, Chen A, Krauser D,
Tung R et al. Renal Function, Congestive heart failure, and aminoterminal Pro-brain natriuretic
measurement; result
from the
ProBNP Investigation of Dyspnea in the Emergency Department
( PRIDE ) Study. J Am Coll Cardiol 2006;47;917
13. Swanton RH, Banerjee S. Cardiac failure. In: Swanton’s Cardiology.
6th edition. Blackwell. 2008. P:255
14. Disalvo T. The Clinical Syndrome of Heart Failure. In: Heart Failure
Acomprehensive Guide to Diagnosis and Treatment. Ed: G William
Dec. Marcell Dekker. USA. P: 18,189.
15. Fuster
V, Rourke RA, Walsh RA, Poole-Wilson P, King III SB,
Robert R, et al. Hurst’s The Heart, ed 12. The McGraw-Hill
Companies, 2008. Chapter 24, 25, 26.
16. Dumitru I. Heart Failure. Medscape, 2013.
17. Scoote M, Purcell IA, Poole-Wilson PA. Pathophysiology of Heart
Failure. In; Essential Cardiology Principle and Practice. 2nd Edition.
Ed: CLIVE ROSENDORFF. Humana Press. USA. P: 354-367
18. Herman et al. Basics of natriuretic peptides: practical aspects of
assays, potential analytical confounders, and clinical interpretation.
In : Markers in Cardiology. ed: Allan B Wu. Humana Press. USA
2003. P : 99-103
19. Maisel AM. Rapid Measurement OF B-Type Natriuretic Peptide in
the Emergency Diagnosis of Hearth Failure. The New England
Journal of Medicine. July 2008.
20. Omland T, Waehre T. Natriuretic peptides and inflammatory
markers for risk stratification in patients with ischemic heart
64
65
disease. In:Biomarkers in Heart Disease. 1st edition.Ed: James A de
Lemos. American Heart Association. 2008. P:55-59
21. Maisel AM. Natriuretic peptide in clinical practice. In: marker in
Cardiology. Ed: Jesse E Adam. Blackwell Publishing.USA.P:134142.
22. Roundtable discussion. Testing for B-type natriuretic peptide in the
diagnosis and assessment of heart failure: What are the nuances?
Cleveland Clinic Juornal of Medicine. 2004
23. Doust J, Lehman R, Glasziou P. The Role of BNP Testing in Heart
Failure. Am Fam Physician 2006;74:1893-8
24. Jackson G et al. ABC of heart failure Pathophysiology. British
Medical Journal. BMJ Volume 320 15 January 2000
25. Dahlen
JR.
B-Type
Natriuretic
Peptide
Biochemistry
and
Measurement. In: Markers in Cardiology. ed: Allan B Wu. Humana
Press. USA 2003. P : 369-71
26. McCullough PA, Duc P, Omland T, et al. B-type natriuretic peptide
and renal function in the diagnosis of heart failure: an analysis from
the Breathing Not Properly Multinational Study. Am J Kidney Dis
2003; 41:571–579
27. Weintraub NL et al. Acute Heart Failure Syndromes: Emergency
Department Presentation, Treatment, and Disposition: Current
Approaches and Future Aims : A Scientific Statement From the
American Heart Association. Circulation Journal the American Heart
Association. AHA. October 2010
28. Rademaker MT, Richard AM. Cardiac Natriuretic Peptide for
cardiac health. Clin Sci ( Lond ).2005;108 (1):23-36
29. Pfister R et al. Use of NT-proBNP in routine testing and
comparison to BNP. The European Journal of Heart Failure.
Elsevier.2004
30. Boyars MC et al. Acute dyspea : a sign of underlying disease :
review of clinical sign.Hospital physician july 2004.pp 23-27.
31. Roche. Cobas 6000. In : Roche diagnostik.
65
66
32. Roche. Cobas
33. Mulrow C, Lucey C, Farnett L. Diskriminating cause of dyspnea
through the Clinical examination. J Gen Intern Med 1993;8:383-92.
34. Schmitt B, Kushrer M, Wiener S. The diagnostic usefulness of
history of the patient with dyspnea. J Gen Intern Med 1986;386-93
35. Morrison KL, BS, et all, Journal of American College of Cardiology
2002, Elsevier Saence Inc. vol.39,no 2,2002.
36. Murray H, Cload B, Collier CP,et all, Potential impact of N-terminal
pro-BNP testing on the emergency department evaluation of acute
dyspnea. Can J Emerg Med 2006;8(4):251-8.
37. Januzzi JL. Kimmenade RV, et all. NT-proBNP (ICON). Testing for
diagnostic and short term prognostis in acute destabilized heart
failure; an International pooled analysis of 1256 patient. The
International Collaborative of NT-proBNP (ICON) study. Eur J Heart
Failure.2006;27:330-7.
66